Home / Business and Economy / Gaudium IVF IPO: Retail Investors Show Interest, QIBs Lag
Gaudium IVF IPO: Retail Investors Show Interest, QIBs Lag
24 Feb
Summary
- Gaudium IVF IPO received a subscription of 1.78 times by Monday afternoon.
- Retail and NII investors showed strong interest, oversubscribing their quotas.
- The company raised ₹49.5 crore from anchor investors prior to the IPO.
The initial public offering (IPO) for Gaudium IVF and Women Health has seen a mixed response from investors.
As of Monday, February 23, at 11:40 AM, the IPO was subscribed 1.78 times, with 25.96 million shares bid for against 14.62 million shares on offer.
Retail investors demonstrated strong engagement, subscribing approximately 2.55 times their reserved quota, while non-institutional investors booked around 2.33 times their portion. However, qualified institutional buyers (QIBs) showed minimal interest, subscribing to only 1 per cent of their allocated shares.
Prior to the public issue, Gaudium IVF successfully raised ₹49.5 crore from anchor investors. These investors, including Meru Investment Fund and Sanshi Fund, were allocated 6.26 million equity shares at the upper price band of ₹75 to ₹79 per share.
The ₹165 crore IPO, which comprises a fresh issue and an offer for sale, is set to close for subscription on Tuesday, February 24. The basis of allotment is expected by Wednesday, February 25, with tentative listing dates on BSE and NSE scheduled for Friday, February 27. The company plans to use ₹50 crore for new IVF centre establishments and ₹20 crore for debt repayment.
